The most common GI side effect
Avraham SA, Hossein J, Somri F, Hawash N, Hochman O (2024) Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss
Our products are manufactured and tested in the EU
Raloxifene encapsulated spanlastic nanogel for the prevention of bone fracture risk via transdermal administration: Pharmacokinetic and efficacy study in animal model
In a randomized trial, patients with laryngopharyngeal reflux disease (LPRD) were enrolled were given oral vonoprazan and saliva specimens were collected before and after treatment, and Neisseria, Burkholderia , and Leptospira were found to be more prevalent in the LPRD group than in the post-LRPD group
GLP-1 RAs may also improve liver function, this effect is thought to involve activation of AMP-activated protein kinase (AMPK), a key metabolic regulator that inhibits fatty acid synthesis and promotes fatty acid -oxidation, leading to decreased lipid accumulation in hepatocytes 22,23,24,25